Skip to content
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Otolaryngology

What Is Primary vs. Secondary Endolymphatic Hydrops?

At a Glance

Primary endolymphatic hydrops means inner-ear fluid buildup without a known trigger, while secondary hydrops is linked to another condition, injury, or disease. Hydrops on MRI does not by itself prove Ménière’s disease or explain symptoms.

Hydrops describes a change in inner-ear fluid; it is a physical or imaging finding, not a final clinical diagnosis. When doctors use the term primary (or idiopathic) endolymphatic hydrops, they mean the fluid imbalance occurs without a known trigger—this is often associated with the clinical diagnosis of Ménière’s disease [1]. Secondary endolymphatic hydrops involves the same fluid buildup, but it happens as a result of, or in association with, another identifiable disease, injury, or condition [2][3].

When investigating your symptoms, doctors aim to find out why the fluid buildup is happening. Identifying a secondary cause can open doors to treatments that address the root issue rather than just managing symptoms [4][3].

⚠️ When to Seek Urgent Care
While working with your doctor to find a diagnosis, seek immediate medical attention if you experience:

  • Sudden or rapidly worsening hearing loss
  • New neurological symptoms (like numbness, weakness, or facial drooping)
  • Inability to walk or stand
  • A severe, unusual, or sudden headache
  • Fainting or loss of consciousness
    Do not wait for a routine inner-ear evaluation if these time-sensitive symptoms occur.

Endolymphatic Hydrops vs. Ménière’s Disease

It is important to understand that endolymphatic hydrops and Ménière’s disease are not exactly the same thing.

  • Ménière’s disease is a clinical syndrome diagnosed by a specific pattern of symptoms: episodic vertigo, fluctuating hearing loss, tinnitus (ringing in the ear), and aural fullness [1][5].
  • Endolymphatic hydrops is the physical swelling of the inner ear compartments. While it is often considered a key physical feature of Ménière’s disease, it is neither required nor sufficient to make the diagnosis [6]. Hydrops can occur with other conditions, or even without any symptoms at all [6].

Reported Associations and Secondary Causes

A wide variety of conditions have been linked to secondary endolymphatic hydrops. Rather than being equally common, these range from established causes to rare associations and “mimics” that produce similar symptoms [2][3]:

  • Prior Ear Surgery or Otosclerosis: Previous procedures, such as cochlear implantation or a stapedectomy (surgery to replace a middle ear bone), can cause scarring that may disrupt fluid balance [7][8]. Otosclerosis, an abnormal stiffening of the middle ear bones, is also linked to secondary hydrops [3].
  • Trauma: Physical injury to the head, temporal bone fractures, or severe acoustic trauma (extreme noise exposure) can trigger inflammation associated with hydrops [9][10].
  • Infection and Inflammation: Severe ear infections like suppurative labyrinthitis (bacterial infection of the inner ear) or chronic otitis media (long-term middle ear infection) can damage inner ear tissues [11][12]. Systemic autoimmune diseases or immune-mediated inner-ear disease can also trigger inflammatory fluid buildup [13].
  • Cerebrospinal Fluid (CSF) Pressure Disorders: Changes in brain fluid pressure can sometimes transmit to the inner ear. Conditions like spontaneous intracranial hypotension (low brain fluid pressure, often causing headaches that worsen when standing) have been associated with hydrops-like symptoms [14][15].
  • Tumors (Rare): Benign growths such as vestibular schwannomas (acoustic neuromas) or endolymphatic-sac tumors can occasionally compress or obstruct inner ear structures [16][17]. These are uncommon but important to evaluate for.
  • Congenital Malformations (Rare): Being born with abnormally shaped inner ear structures, such as an underdeveloped balance canal (hypoplasia), is a rare association with fluid buildup [18][19].

Finding the Underlying Cause: The Targeted Workup

Because these causes and mimics vary so widely, doctors do not rely on an indiscriminate “hydrops panel” of blood tests. Instead, they use a targeted approach [3][5]:

  • Targeted Medical History and Exam: Your doctor will look for clues such as prior ear infections, surgeries, head injuries, loud noise exposure, and medications [3]. They will also ask about neurological symptoms (like posture-related headaches) or autoimmune symptoms to guide testing [15][20].
  • Audiometry (Hearing Tests): Serial hearing tests track how your hearing changes over time. Finding a low-frequency sensorineural hearing loss versus a conductive gap can help guide further evaluation to distinguish between Ménière’s disease and structural problems like superior canal dehiscence (a thinning of the bone over the inner ear) [5][21].
  • Selective Imaging: Imaging is used carefully based on your symptoms [22]. A specialized MRI of the internal auditory canals may be ordered to check for vestibular schwannomas, while a high-resolution temporal bone CT scan looks for bony malformations [5][23]. A delayed gadolinium-enhanced MRI can sometimes visualize the hydrops itself, but it cannot determine if the hydrops is primary, secondary, or clinically responsible for your symptoms.
  • Targeted Laboratory Testing: Blood tests are ordered only when your history suggests a specific underlying issue, such as markers for systemic inflammation, rather than as a routine screening [13].

Why the Root Cause Matters (And What If None Is Found)

An MRI report mentioning “endolymphatic hydrops” should not dictate your treatment by itself [6]. In some research cohorts using specific scanning protocols, mild hydrops has been detected in up to 31% of healthy individuals with no ear symptoms at all, as well as in patients with conditions like vestibular migraine [6].

If a secondary cause is identified, treating that root issue may improve your symptoms. For example, managing a spinal fluid leak with a blood patch when clinically appropriate and evaluated by specialists can sometimes relieve secondary ear symptoms [4]. Vestibular schwannomas can be managed with observation, radiation, or surgery depending on the patient’s needs and tumor characteristics [24]. Interestingly, patients often report that their dizziness and vertigo improve significantly with symptom-based treatments even if follow-up MRIs show that the inner ear fluid has not completely resolved [25][26].

What if no secondary cause is found?
It is very common for evaluations to find no secondary cause, leading to a diagnosis of primary/idiopathic hydrops or Ménière’s disease. This does not mean your symptoms are untreatable. If no root cause is found, your care team will focus on symptom-directed care—such as dietary modifications, medications to manage vertigo, hearing support, and vestibular rehabilitation—to help you safely manage symptoms and protect your long-term quality of life.

Common questions in this guide

What is the difference between primary and secondary endolymphatic hydrops?
Primary, or idiopathic, endolymphatic hydrops means inner-ear fluid buildup occurs without an identified trigger. Secondary hydrops occurs in connection with another condition, injury, disease, or procedure, so evaluation focuses on finding and treating that underlying issue.
Does endolymphatic hydrops mean I have Ménière’s disease?
No. Ménière’s disease is diagnosed from a pattern of episodes of vertigo, fluctuating hearing loss, tinnitus, and a feeling of ear fullness; hydrops is a physical or imaging finding that may occur with or without those symptoms and is not required or sufficient for the diagnosis.
What can cause secondary endolymphatic hydrops?
Possible associations include previous ear surgery, otosclerosis, head or temporal-bone injury, severe noise exposure, serious ear infection, autoimmune inner-ear inflammation, changes in the pressure of the fluid around the brain and spinal cord, and rarely tumors or congenital inner-ear differences. The likelihood of each cause depends on your history and examination.
How do doctors investigate whether hydrops is secondary?
They usually start with a medical history and ear and neurologic examination, then use hearing tests over time to look for patterns. MRI or temporal-bone CT and blood tests are selected based on symptoms and suspected causes rather than ordered as a routine all-purpose panel.
Can an MRI show whether hydrops is causing my symptoms?
A specialized MRI may show inner-ear hydrops, but it cannot by itself tell whether the hydrops is primary or secondary or whether it explains your symptoms. Mild hydrops can appear in people without ear symptoms and in some people with vestibular migraine.
What treatment is used if no secondary cause is found?
When no underlying cause is identified, clinicians may consider primary or idiopathic hydrops or Ménière’s disease and focus on symptom-directed care. Options discussed on this page include dietary changes, medicines for vertigo, hearing support, and vestibular rehabilitation.
When should I seek urgent care with suspected hydrops?
Seek immediate medical attention for sudden or rapidly worsening hearing loss, new neurologic symptoms, inability to walk or stand, a severe unusual or sudden headache, fainting, or loss of consciousness. These symptoms should not wait for a routine inner-ear evaluation.

Get notified when new evidence is published on endolymphatic hydrops.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    Imaging of endolymphatic hydrops: A comprehensive update in primary and secondary hydropic ear disease.

    Eliezer M, Attyé A, Toupet M, Hautefort C

    Journal of vestibular research : equilibrium & orientation 2021; (31(4)):261-268 doi:10.3233/VES-200786.

    PMID: 33646188
  2. 2

    Secondary endolymphatic hydrops: a clinical and literature overview.

    Venkatasamy A, Péporté ARJ

    Frontiers in neurology 2024; (15()):1525954 doi:10.3389/fneur.2024.1525954.

    PMID: 39975852
  3. 3

    Secondary Endolymphatic Hydrops.

    Ferster APO, Cureoglu S, Keskin N, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2017; (38(5)):774-779 doi:10.1097/MAO.0000000000001377.

    PMID: 28306649
  4. 4

    Spontaneous Intracranial Hypotension May Be an Under-recognized Cause of Endolymphatic Hydrops.

    Sakano H, Jafari A, Allehaiby W, Harris JP

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2020; (41(7)):e860-e863 doi:10.1097/MAO.0000000000002665.

    PMID: 32472922
  5. 5

    [Clinical and diagnostic criteria and differential diagnosis in the first and second stages of the development of Ménière's disease - A modern view of the problem].

    Kryukov AI, Kunelskaya NL, Zelikovich EI, et al.

    Vestnik otorinolaringologii 2021; (86(5)):4-11 doi:10.17116/otorino2021860514.

    PMID: 34783466
  6. 6

    The "hype" of hydrops in classifying vestibular disorders: a narrative review.

    van der Lubbe MFJA, Vaidyanathan A, Van Rompaey V, et al.

    Journal of neurology 2020; (267(Suppl 1)):197-211 doi:10.1007/s00415-020-10278-8.

    PMID: 33201310
  7. 7

    Human Temporal Bone Study of Vestibular Histopathology in Cochlear Implant Patients With Cochlear Hydrops.

    Su-Velez BM, Lopez IA, Ishiyama A, Ishiyama G

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2020; (41(5)):e607-e614 doi:10.1097/MAO.0000000000002609.

    PMID: 32150024
  8. 8

    Insights and Constraints: Understanding the Boundaries in Investigating Otosclerosis and Endolymphatic Hydrops Interaction.

    Castillo-Bustamante M, Guajardo-Vergara C, Armato E

    Cureus 2025; (17(12)):e99962 doi:10.7759/cureus.99962.

    PMID: 41450711
  9. 9

    Secondary Endolymphatic Hydrops After Acoustic Trauma.

    Chen YJ, Young YH

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2016; (37(5)):428-33 doi:10.1097/MAO.0000000000001036.

    PMID: 27093028
  10. 10

    Focal Endolymphatic Hydrops as Seen in the Pars Inferior of the Human Inner Ear.

    Nadol JB

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2016; (37(7)):859-64 doi:10.1097/MAO.0000000000001094.

    PMID: 27273408
  11. 11

    Quantitative Assessment of Cochlear Histopathologic Findings in Patients With Suppurative Labyrinthitis.

    Kaya S, Tsuprun V, Hizli Ö, et al.

    JAMA otolaryngology-- head & neck surgery 2016; (142(4)):364-9 doi:10.1001/jamaoto.2015.3803.

    PMID: 26987015
  12. 12

    Cochlear changes in serous labyrinthitis associated with silent otitis media: A human temporal bone study.

    Kaya S, Tsuprun V, Hızlı Ö, et al.

    American journal of otolaryngology 2016; (37(2)):83-8.

    PMID: 26954857
  13. 13

    Intratympanic gadolinium magnetic resonance imaging supports the role of endolymphatic hydrops in the pathogenesis of immune-mediated inner-ear disease.

    Lobo D, Tuñón M, Villarreal I, et al.

    The Journal of laryngology and otology 2018; (132(6)):554-559 doi:10.1017/S0022215118000749.

    PMID: 29888688
  14. 14

    Bilateral Sensorineural Hearing Loss Related to a Skull Base Spontaneous Cerebrospinal Fluid Leak: A Case Report and Literature Review.

    Gaini LM, Battilocchi L, Conte G, et al.

    Ear, nose, & throat journal 2025; (104(2_suppl)):255S-260S doi:10.1177/01455613231191372.

    PMID: 37551677
  15. 15

    The neurologist and the hydrops.

    Redon S, Elzière M, Donnet A

    Journal of vestibular research : equilibrium & orientation 2021; (31(4)):303-309 doi:10.3233/VES-200790.

    PMID: 33843710
  16. 16

    Endolymphatic Hydrops in the Setting of Vestibular Schwannoma: A Temporal Bone Study.

    Wong YT, Lopez IA, Wichova H, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2023; (44(1)):81-85 doi:10.1097/MAO.0000000000003754.

    PMID: 36509446
  17. 17

    Intraoperative Electrocochleography of Posterior Fossa Tumors Producing Menière's Syndrome.

    Varadarajan VV, Riggs WJ, Hiss MM, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2020; (41(10)):e1237-e1242 doi:10.1097/MAO.0000000000002800.

    PMID: 32810016
  18. 18

    Ratio of Vestibular Endolymph in Patients with Isolated Lateral Semicircular Canal Dysplasia.

    Naganawa S, Kawai H, Sone M, Ikeda M

    Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine 2015; (14(3)):203-10 doi:10.2463/mrms.2014-0112.

    PMID: 25833266
  19. 19

    Magnetic resonance imaging: Role on diagnosing all types of endolymphatic hydrops.

    Lin KT, Lu CJ, Young YH

    Journal of the Formosan Medical Association = Taiwan yi zhi 2022; (121(7)):1325-1333 doi:10.1016/j.jfma.2021.08.027.

    PMID: 34686411
  20. 20

    Endolymphatic Hydrops Secondary to Spontaneous Intracranial Hypotension.

    Poillon G, Hautefort C, Levy D, Eliezer M

    Headache 2020; (60(8)):1812-1813 doi:10.1111/head.13866.

    PMID: 32542657
  21. 21

    Endolymphatic hydrops in superior canal dehiscence and large vestibular aqueduct syndromes.

    Sone M, Yoshida T, Morimoto K, et al.

    The Laryngoscope 2016; (126(6)):1446-50 doi:10.1002/lary.25747.

    PMID: 26525170
  22. 22

    Magnetic resonance imaging of the inner ear in the diagnostics of Ménière's disease.

    Jasińska A, Lachowska M, Wnuk E, Niemczyk K

    Otolaryngologia polska = The Polish otolaryngology 2020; (75(2)):1-8 doi:10.5604/01.3001.0014.6176.

    PMID: 33949313
  23. 23

    Advanced Imaging of the Vestibular Endolymphatic Space in Ménière's Disease.

    Zanetti D, Conte G, Scola E, et al.

    Frontiers in surgery 2021; (8()):700271 doi:10.3389/fsurg.2021.700271.

    PMID: 34497826
  24. 24

    Vestibular Schwannoma and Ipsilateral Endolymphatic Hydrops: An Unusual Association.

    Ralli M, Greco A, Altissimi G, et al.

    The international tinnitus journal 2017; (21(2)):128-132 doi:10.5935/0946-5448.20170024.

    PMID: 29336131
  25. 25

    Temporal changes in endolymphatic hydrops on MRI with or without intervention: A systematic review.

    Mavrommatis MA, Kaul VF, Chow K, et al.

    American journal of otolaryngology 2023; (44(2)):103764 doi:10.1016/j.amjoto.2022.103764.

    PMID: 36587603
  26. 26

    Imaging Analysis of Patients With Meniere's Disease Treated With Endolymphatic Sac-Mastoid Shunt Surgery.

    Li Y, Lv Y, Hu N, et al.

    Frontiers in surgery 2021; (8()):673323 doi:10.3389/fsurg.2021.673323.

    PMID: 35096954

This page is for informational purposes only and does not constitute medical advice or diagnose the cause of endolymphatic hydrops. Discuss your symptoms and test results with your healthcare professional.